Products billed under this code include mNEXSPIKE 2025-26 (12Y UP) 10 MCG/0.2 ML SYRG.
Payment limit per 10 MCG, by effective quarter, 4Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| mNEXSPIKE 2025-26 (12Y UP) 10 MCG/0.2 ML SYRG | Moderna | 80777-0400-60 | 10 | $2,522.25 |
| mNEXSPIKE 2025-26 (12Y UP) 10 MCG/0.2 ML SYRG | Moderna | 80777-0400-61 | 2 | $504.45 |
| mNEXSPIKE 2025-26 (12Y UP) 10 MCG/0.2 ML SYRG | Moderna | 80777-0400-62 | 1 | $252.225 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $252.225 | +$50.312 | 10 MCG | SARSCOV2 VAC 10 MCG/0.2ML IM | v1, posted September 17, 2026 |
| 3Q26 | $201.913 | $0.00 | 10 MCG | SARSCOV2 VAC 10 MCG/0.2ML IM | v1, posted September 15, 2026 |
| 2Q26 | $201.913 | $0.00 | 10 MCG | SARSCOV2 VAC 10 MCG/0.2ML IM | v1, posted September 15, 2026 |
| 1Q26 | $201.913 | $0.00 | 10 MCG | SARSCOV2 VAC 10 MCG/0.2ML IM | v1, posted September 15, 2026 |
| 4Q25 | $201.913 | – | 10 MCG | SARSCOV2 VAC 10 MCG/0.2ML IM | v1, posted September 8, 2026 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
